ArticleFrontiers in immunology2025
The prognostic significance of primary tumor laterality in malignant ovarian teratomas: a 10-year experience at a single institution.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Approximately 95% of ovarian teratomas are classified as benign, with only about 5% being malignant. Nevertheless, no research has previously explored the connection between primary tumor laterality and prognostic outcomes among malignant ovarian teratoma (MOT) patients. Our aim was to investigate the association of primary tumor laterality with prognosis in MOT. Methods: This retrospective study enrolled patients with MOT from The Affiliated Hospital of Qingdao University from January 2012 to December 2021. The primary outcome was progression-free survival (PFS) and overall survival (OS). The prognostic difference between left-sided, right-sided and bilateral groups was investigated using Kaplan-Meier analyses and Cox proportional hazards regression analyses. Results: A total of 51 eligible patients with MOT were included with a median age of 52 years. Among the patients with MOT, the multivariate Cox regression analyses showed that right-sided (hazard ratio [HR]=0.01; 95% confidence interval [CI]=0.00-0.04; Conclusion: Among patients with MOT, those with unilateral tumors, particularly right-sided ones, had a significantly better prognosis than those with bilateral tumors. Gynecologic oncologists might account for the prognostic impact of primary tumor laterality in MOT and tailor treatment and surveillance accordingly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.